The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …

Background Care for patients with colon and rectal cancer has improved in the last 20 years;
however considerable variation still exists in cancer management and outcome between …

Background The last 30 years have witnessed a significant increase in the diagnosis of early-
stage rectal cancer and the development of new strategies to reduce the treatment-related …

BACKGROUND Pancreatic cancer diagnosis and staging can be difficult in 10-20% of
patients. Positron emission tomography (PET)/computed tomography (CT) adds precise …

Positron emission tomography/computed tomography (PET/CT) integrated with 2-[18 F]
fluoro-2-deoxy-D-glucose (FDG) is a useful tool for acquisition of both glucose metabolism …

Introduction: With the advent of multidisciplinary and multimodality approaches to the
management of colorectal cancer patients, there is an increasing need to define how we …

Introduction Rhabdomyosarcoma (RMS) management depends on risk stratification at
diagnosis and treatment response. Assessment methods include CT, MRI, bone …

BACKGROUND Breast cancer and its treatment can have an impact on health-related
quality of life and survival. Tumour profiling tests aim to identify whether or not women need …

Imaging techniques are clinical decision-making tools in the evaluation of patients with
colorectal cancer (CRC). The aim of this article is to discuss the potential of recent advances …